Trial Profile
Phase I Study to Determine Safety of Pioglitazone Combined With Radiation Therapy in Subjects With Brain Tumors
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Feb 2013
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Cognition disorders
- Focus Adverse reactions
- 25 Jan 2013 Planned End Date changed from 1 Jan 2013 to 1 Sep 2014 as reported by ClinicalTrials.gov record.
- 02 May 2012 New trial record